In the top September M&A by deal value, Enovis entered into a definitive agreement to acquire LimaCorporate for an enterprise value of approximately $851.48m in cash and stock. Lima is a privately held orthopedic company focused on restoring motion through a portfolio of implant solutions. The company specializes in additive manufacturing, including its proprietary trabecular titanium (TT) technology. The addition of Lima will give Enovia a complementary portfolio of proven surgical solutions and technologies, including 3D printed TT and a comprehensive revision offering. Financing reached $12.5bn in biopharma, $233m in device, and $487m in diagnostics.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?